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Abstract
Both theoretical and applied studies have proven that the utility of single nucleotide polymorphism
(SNP) markers in linkage analysis is more powerful and cost-effective than current microsatellite
marker assays. Here we performed a whole-genome scan on 115 White, non-Hispanic families
segregating for alcohol dependence, using one 10.3-cM microsatellite marker set and two SNP data
sets (0.33-cM, 0.78-cM spacing). Two definitions of alcohol dependence (ALDX1 and ALDX2) were
used. Our multipoint nonparametric linkage analysis found alcoholism was nominal linked to 12
genomic regions. The linkage peaks obtained by using the microsatellite marker set and the two
SNP sets had a high degree of correspondence in general, but the microsatellite marker set was
insufficient to detect some nominal linkage peaks. The presence of linkage disequilibrium between
markers did not significantly affect the results. Across the entire genome, SNP datasets had a much
higher average linkage information content (0.33 cM: 0.93, 0.78 cM: 0.91) than did microsatellite
marker set (0.57). The linkage peaks obtained through two SNP datasets were very similar with
some minor differences. We conclude that genome-wide linkage analysis by using approximately
5,000 SNP markers evenly distributed across the human genome is sufficient and might be more
powerful than current 10-cM microsatellite marker assays.
Background
In traditional linkage analysis for identifying genomic
regions related to disease phenotypes, a whole-genome
scan is usually performed using a set of 300–400 micros-
atellite markers evenly spaced across the genome. To max-
imize the chances of detecting linkage, the optimal
amount of inheritance information is critical. This can be
increased by genotyping more families and adding addi-
tional markers. With the rapid discovery of SNPs across
the genome and the development of large-scale, high-
throughput SNP genotyping approaches, high-density
SNP assays throughout the genome may be a more rapid,
powerful, and cost-effective tool than microsatellite
marker assays in linkage analysis [1]. Recently, both sim-
ulation and applied studies have shown that high-density
SNPs across the genome may offer several advantages over
a low density microsatellite marker set, including
increased power to detect linkage [2-4] and more precise
mapping of the disease phenotype susceptibility loci [5].
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(COGA) data provided to participants in the Genetic
Analysis Workshop 14 (GAW14) included one 10-cM
microsatellite marker set and two high-density SNP geno-
type datasets, which offered a good opportunity to test the
benefit of high-density SNPs relative to lower-density mic-
rosatellite markers in a whole-genome linkage scan.
Methods
Phenotype definition
The COGA dataset provided to participants in GAW14
was analyzed in this study. Only families with ethnicity
self-reported as White, non-Hispanic were kept for analy-
sis. Two diagnostic criteria for alcoholism were used in
our analyses. For the first criterion, a diagnosis of alcohol-
ism required positive diagnosis by the DSM-III-R criteria
[6] and definite "alcoholism" by the Feighner criteria [7].
This is referred to as the COGA criterion for ALDX1. For
the second criterion, a diagnosis of alcoholism only
required positive diagnosis by the DSM-IV criterion [8],
which is referred to as the COGA criterion for ALDX2. For
each criterion, we classified individuals who are coded as
"pure unaffected" under the COGA definition as unaf-
fected. Individuals who showed some alcohol-related syn-
dromes, but did not meet the criterion for affected and
those who never drank alcohol were classified as "affec-
tion status unknown."
Genetic maps and linkage disequilibrium
SNP genetic map positions were interpolated on the
deCODE genetic map [9] through use of their physical
positions (NCBI genome build 34.3); markers not placed
were discarded. Since strong linkage disequilibrium (LD)
might exist among some of the closely spaced SNPs and
LD between SNPs might generate inflated linkage signals,
Linkage information content of high-density SNPs vs. microsatellitesFigur 1
Linkage information content of high-density SNPs vs. microsatellites.
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we used Haploview (version 3.0) [10] to define LD blocks
(default method) and selected only one tagging SNP with
the highest heterozygosity among SNPs within each
defined block.
Linkage analysis
We performed multipoint nonparametric linkage analysis
using an affected-only allele-sharing method, which was
implemented in the ALLEGRO (version 1.2c) software
[11]. We employed the Spairs scoring function [12], which
performs well for all disease models, and the exponential
allele-sharing model [13] to generate the relevant test sta-
tistics. Family scores were combined to obtain an overall
score, using a weighting scheme that each family should
be weighted proportionally to the standard deviation of
the score function used, under the null hypothesis of no
linkage, to the power 0.5, which is considered about mid-
way between weighting each pair equally versus weighting
each family equally [14].
Results
We used 115 White, non-Hispanic families in our analy-
sis. The total number of individuals was 1,245, of which
1,009 were genotyped. Linkage information content for
two SNP datasets was very similar except that the less-
dense Illumina set had lower linkage information content
on the X chromosome due to its poor coverage (Figure 1).
Both SNP datasets had significantly higher linkage infor-
mation content and better coverage than microsatellite
marker data throughout the entire genome (Table 1).
For both definitions of alcohol dependence (ALDX1 and
ALDX2), we found 12 genomic regions with nominally
significant LOD scores (p < 0.05, Table 2). There was good
concordance between the two SNP datasets in linkage
peaks, except for the second peak on chromosome 6. We
detected the linkage peaks discovered by the microsatellite
marker assay with slightly higher LOD scores in both SNP
datasets, with the exception of one peak on chromosome
21. We also detected two additional linkage peaks in both
SNP datasets that were missed in microsatellite assay. This
was likely due to low linkage information content (chro-
mosome X) or poor coverage (chromosome 6).
Impact of the presence of LD was investigated by using the
Affymetrix SNPs set, which had many LD blocks across the
genome, and the results were not significantly changed
when the analysis was restricted to SNPs in linkage equi-
librium compared with the analysis without considering
LD (Table 2).
Table 1: Marker information.
Dataset Number Average spacing (SD) Information content (SD)
Affymetrix SNPs 11,115 0.326 cM (0.615) 0.93 (0.037)
Illumina SNPs 4,720 0.775 cM (1.173) 0.91 (0.044)
Microsatellites 328 10.316 cM (7.656) 0.57 (0.18)
Table 2: Maximal LOD scores for loci with increased allele sharing at p < 0.05.
ALDX1 LOD (p) ALDX2 LOD (p)
Affymetrix Illumina Microsatellite
s
Affymetrix Illumina Microsatellite
s
LD No LD
Chr 2 (2p25) 1.38 (0.005) 1.28 (0.007) 1.84 (0.002) 1.19 (0.009) 0.65 (0.04) 1.11 (0.01) 0.79 (0.03)
Chr 2 (2q13) 1.88 (0.002) 1.75 (0.002) 1.26 (0.008) 0.94 (0.02) 1.16 (0.01) 0.78 (0.03) 1.17 (0.01)
Chr 3 (3p21) 1.18 (0.01) 1.24 (0.008) 1.30 (0.007) 0.47 (0.07) 1.10 (0.01) 0.95 (0.02) 0.66 (0.04)
Chr 6 (6p24) 1.26 (0.008) 1.07 (0.01) 1.25 (0.008) 0.65 (0.04) 1.57 (0.003) 1.17 (0.01) 0.12 (0.2)
Chr 6 (6q27) 0.79 (0.03) 0.65 (0.04) 2.41 (0.0004) - 0.95 (0.02) 2.08 (0.001) -
Chr 7 (7p21) 1.69 (0.002) 1.64 (0.003) 1.15 (0.01) 1.16 (0.01) 1.84 (0.002) 1.40 (0.005) 1.01 (0.01)
Chr 9 (9q34) 0.90 (0.02) 0.81 (0.03) 1.17 (0.01) 0.28 (0.1) 1.53 (0.004) 1.72 (0.002) 0.08 (0.3)
Chr 10 (10q24) 1.02 (0.01) 0.62 (0.04) 1.21 (0.009) 0.91 (0.02) 1.83 (0.002) 2.43 (0.0004) 0.90 (0.02)
Chr 10 (10q26) 1.58 (0.003) 1.35 (0.007) 1.43 (0.005) 0.96 (0.02) 1.23 (0.008) 1.47 (0.004) 0.71 (0.03)
Chr 12 (12q24) 1.55 (0.004) 1.00 (0.02) 1.24 (0.008) 1.56 (0.004) 1.57 (0.003) 1.33 (0.006) 1.71 (0.002)
Chr 21 (21q22) 0.28 (0.1) 0.20 (0.2) 0.28 (0.1) 1.77 (0.002) 0.29 (0.1) 0.13 (0.2) 1.09 (0.01)
Chr X (xp22) 2.22 (0.0007) - 2.17 (0.0007) 0.43 (0.08) 0.74 (0.03) 0.80 (0.03) 0.07 (0.3)
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Discussion
This study supports the benefit of using of a high-density
SNP marker set compared with a microsatellite marker
assay in linkage analysis. Although there were only minor
differences between the results from the two scans, the tra-
ditional microsatellite approach failed to detect some
nominal linkage peaks due to lower linkage information
content and poor coverage. The peaks on chromosome 6
(6q27) and X (Xp22) in the SNP assays were two exam-
ples of signals not detected in the microsatellite analyses.
The good concordance between the two SNP marker sets
(Affymetrix and Illumina) in both linkage information
content and linkage findings suggests that >5,000 SNPs
may be excessive for samples with structures similar to the
COGA data, and a SNP scan with ~5,000 markers distrib-
uted evenly across the human genome is sufficiently
dense and powerful in whole-genome linkage analysis.
Also, with current technology SNP genotyping is more
rapid, requires fewer samples, and is more accurate than
microsatellite marker genotyping. High-density SNP
marker sets also offer a better localization of linkage
peaks, which may save work for fine mapping in regions
showing linkage [4]. Since bi-allelic SNP markers are less
informative than polymorphic microsatellite markers, the
multipoint method is a better choice for SNP assays. How-
ever, estimation of genetic maps for SNPs is less precise
than for microsatellite markers due to their lower levels of
heterozygosity [15]. The computational burden increases
dramatically as the number of markers increases. These
disadvantages might limit the use of SNPs in whole-
genome linkage scans.
Our analysis found nominal linkage for alcoholism to 12
genomic regions under both definitions for alcohol
dependence (ALDX1 and ALDX2). The results for the two
phenotype definitions are somewhat different. It is not
clear which criterion is best for identifying genetic suscep-
tibility loci for alcoholism. However, if one genomic
region is associated with alcoholism, there should be sim-
ilar statistical evidence under both criteria. Our finding on
chromosome 2 overlaps with that of Reich et al. [16], who
reported linkage of alcoholism to 2q13. Two important
alcohol-related enzymes are located close to chromo-
somal regions where we found nominal linkage: the alde-
hyde dehydrogenase 2 family (ALDH2) is located on
12q24.2 and the cytochrome P450, family 2, subfamily E,
polypeptide 1 (CYP2E1) is in 10q24.3–10q26.3 (Table
2). Our finding on chromosome X (Xp22), which showed
evidence of linkage to mental retardation [17], sounds
interesting for further investigation to explore gender dif-
ferences for alcoholism.
Conclusion
We conclude that a high-density SNP scan may offer a
more rapid, cost-effective and powerful tool in genome-
wide linkage analysis compared to traditional 10-cM mic-
rosatellite marker scans. However, further investigation is
warranted to explore the effects of genetic map and com-
putational issues on the utility of high density SNP assays
in linkage analysis.
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